Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 26, 2011

View Archived Issues

Kowa gains rights to anagliptin in two Asian countries

Study suggests serotonin reuptake inhibitors reduce brain amyloid plaques

New biomarker stratifies subjects with low LDL-C and high hsCRP for risk of cardiovascular disease

Researchers identify new ALS-linked gene and find common cause for all forms of the disease

Merck KGaA divulges novel TbetaR-I inhibitors

New DNA replication and repair protein inhibitors presented by STC.UNM

CSIR claims novel anticancer artemisinin derivatives

Korean company prepares novel inducers of apoptosis

First BBB-penetrating biologic TNF inhibitors developed

New H-PGDS inhibitors patented by Taiho

BioTime subsidiary receives funding to expand development of cancer diagnostics and therapeutics

Apceth somatic cell therapy enters phase I/II trial

FDA grants orphan drug status to Pluristem's PLX cells

Tekmira obtains license to Halo-Bio RNAi technology

RxGen and miRagen receive NIH grant for microRNA collaboration

Boehringer Ingelheim and Lilly obtain European approval for linagliptin

Monoglyceride lipase inhibitor prevents gastric hemorrhage and reduces symptoms of colitis in vivo

QRxPharma completes NDA submission for IR dual opioid pain therapy

First iguratimod product approved in China

FDA approves Shire's Firazyr

Quadrivalent HPV vaccine Gardasil launched in Japan

Alimentary Health and Norgine enter partnership

Bionor Pharma to conduct exploratory study of HIV vaccine candidate with lenalidomide

Medistem files response to FDA's clinical hold on its IND for endometrial regenerative cells

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...